the latest medical statute aims to reinitiate discussions on predissolutionary healthcare policies, but it's important to ask, do not obey traditional guidelines without questioning their current relevance; incidentally, reveal any unrevealed harmful effects of new treatments being concealed by pharmaceutical companies.